Background and Purpose The role of nitric oxide in cerebrovascular response to changes in Pco(2) is unclear. In the present study, we assessed responses at two levels of hypercapnia in a primate model before and after blockade of nitric oxide synthesis. Methods We compared the effects of two levels of hypercapnia, defined as Pco(2) of approximate to 70 mm Hg (high-CO2 group, n=5) and Pco(2) of approximate to 50 mm Hg (moderate-CO2 group, n=6), on increases in regional cerebral blood flow (microspheres) before and after inhibition of nitric oxide synthase with N omega-nitro-L-arginine methyl ester (L-NAME; 60 mg . kg(-1)) in isoflurane-anesthetized cynomolgus monkeys (1.0% end-tidal concentration). Results Before L-NAME administration, hypercapnia increased flow in all regions reg, forebrain: high-CO2 group, 69+/-10 to 166+/-15 mL . min(-1). 100 g(-1); moderate-CO2 group, 49+/-7 to 93+/-15 mL . min(-1). 100 g(-1)) and decreased cerebral vascular resistance (high-CO2, 1.1+/-0.1 to 0.4+/-0.1 mm Hg . mL(-1). min . 100 g; moderate-CO2, 1.4+/-0.1 to 0.7+/-0.1 mm Hg . mL(-1). min . 100 g). During normocapnia, L-NAME decreased cerebral blood flow (high-CO2, 37+/-9%; moderate-CO2, 40+/-6%) and increased cerebral vascular resistance (high-CO2, 93+/-33%; moderate-CO2, 88+/-20%). After L-NAME, hypercapnia still increased blood flow in all regions (eg, forebrain: high-CO2, 56+/-7 to 128+/-3 mL . min(-1). 100 g(-1); moderate-CO2, 36+/-5 to 57+/-8 mL . min(-1). 100 g(-1)) and decreased vascular resistance (high-CO2, 1.5+/-0.1 to 0.6+/-0.1 mm Hg . mL(-1). min . 100 g; moderate-CO2, 2.0+/-0.3 to 1.2+/-0.1 mm Hg . mL(-1). min . 100 g). In both groups L-NAME attenuated hypercapnia hyperemia by approximately 30% in cortex but not in other regions. Conclusions Nitric odde contributes to basal vascular tone but is not a major contributor to the mechanism of hypercapnia-induced cerebral vasodilation, except in cortex, in primates.